Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
AARD holding history
Aardvark Therapeutics, Inc. in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AARD overviewAll 13F holders of AARDFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,000
- Value
- $115.2K
- % of portfolio
- <0.1%
- Quarters held
- 1
- Since Q2 2026